These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16768127)

  • 1. [NASH in children].
    Ida S; Yoshimura N
    Nihon Rinsho; 2006 Jun; 64(6):1168-72. PubMed ID: 16768127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease.
    Fishbein MH; Mogren C; Gleason T; Stevens WR
    J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):83-8. PubMed ID: 16385259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
    Fracanzani AL; Valenti L; Bugianesi E; Vanni E; Grieco A; Miele L; Consonni D; Fatta E; Lombardi R; Marchesini G; Fargion S
    J Hepatol; 2011 Jun; 54(6):1244-9. PubMed ID: 21145841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA; Kunde SS; Lazenby AJ; Clements RH
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic steatohepatitis and the metabolic syndrome.
    Jiang J; Torok N
    Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease.
    Leclercq I
    Bull Mem Acad R Med Belg; 2010; 165(3-4):147-55; discussion 155-8. PubMed ID: 21166266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving trends in nonalcoholic fatty liver disease.
    Delgado JS
    Eur J Intern Med; 2008 Mar; 19(2):75-82. PubMed ID: 18249301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nonalcoholic steatohepatitis in children].
    Cubelić S; Misak Z; Gasparov S; Kolacek S
    Lijec Vjesn; 2004; 126(7-8):197-200. PubMed ID: 15754789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features of NASH].
    Shimada M; Takase S
    Nihon Rinsho; 2006 Jun; 64(6):1114-8. PubMed ID: 16768118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN; Tao RY; Tian JY; Liu GT; Ye F
    Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men.
    Targher G; Bertolini L; Rodella S; Lippi G; Franchini M; Zoppini G; Muggeo M; Day CP
    Obesity (Silver Spring); 2008 Jun; 16(6):1394-9. PubMed ID: 18369343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty liver disease in children.
    Marion AW; Baker AJ; Dhawan A
    Arch Dis Child; 2004 Jul; 89(7):648-52. PubMed ID: 15210498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.
    Tilg H; Moschen AR
    Hepatology; 2010 Nov; 52(5):1836-46. PubMed ID: 21038418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.